Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:46 PM
Ignite Modification Date:
2025-12-24 @ 2:46 PM
NCT ID:
NCT06781359
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of plasmablastic lymphoma (PBL) between Jan 1st 2000, and Dec 31st 2022
* Histologically confirmed plasmablastic lymphoma (PBL) diagnosis according to local pathological report
* Age \> 18 years old
* Availability of complete medical records
* Availability of histopathological material requested by the study
Exclusion Criteria:
* Any other histology than PBL
* Lack of complete medical records
* Lack of histopathological material requested by the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
15 Years
Study:
NCT06781359
Study Brief:
Protocol Section:
NCT06781359